Health
Breast cancer medication risk – Science Codex
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.
Beta-blockers, commonly used to manage cardiovascular disease, were negatively associated with survival outcomes in patients with HER2 (Human Epidermal Growth Factor Receptor 2) positive advanced breast cancer, according to a new paper in the Frontiers In Oncology.
Using data collected from 2,777 patients in clinical trials, the study showed worse survival outco…
-
General11 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business11 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General12 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General14 hours agoAlbanese beats drum on economy as trade clouds gather